A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

NCT07577479 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants Study

Interventions

DRUG: BW-50218 Injection
DRUG: Saline (0.9% NaCl)

Sponsor

Shanghai Argo Biopharmaceutical Co., Ltd.